Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-042332
Filing Date
2017-06-29
Accepted
2017-06-29 16:50:40
Documents
1
Period of Report
2017-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3410
  Complete submission text file 0001209191-17-042332.txt   5767
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA LILLO DEL DUCA, 10 BRESSO L6 20091
Business Address VIA LILLO DEL DUCA, 10 BRESSO L6 20091 39 02665241
Zambon Co SpA (Reporting) CIK: 0001710636 (see all company filings)

State of Incorp.: L6 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 17938912

Mailing Address VIA LILLO DEL DUCA, 10 BRESSO L6 20091
Business Address VIA LILLO DEL DUCA, 10 BRESSO L6 20091 39 02665241
Zambon SpA (Reporting) CIK: 0001710637 (see all company filings)

State of Incorp.: L6 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 17938911